Strategy of cancer targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy

Current Pharmaceutical Biotechnology

Volumn 13, Issue 9, 2012, Pages 1761-1767

  Liu, Xin Yuan ^a,b   Li, Hua Guang ^a   Zhang, Kang Jian ^a   Gu, Jin Fa ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Cancer targeting; Cancer therapy; Gene viro therapy; Trend of gene therapy; Trend of virotherapy

Indexed keywords

ONCOLYTIC ADENOVIRUS K5; ONCOLYTIC ADENOVIRUS RTX; ONCOLYTIC VIRUS; ONCOLYTIC VIRUS ZD55 HSSTR2; ONCOLYTIC VIRUS ZD55 INTERLEUKIN 24; ONCOLYTIC VIRUS ZD55 K5; ONCOLYTIC VIRUS ZD55 SMAC; ONCOLYTIC VIRUS ZD55 TRAIL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER STEM CELL; CANCER TARGETING GENE VIROTHERAPY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; SINGLE DRUG DOSE; THERAPY EFFECT; TUMOR; TUMOR XENOGRAFT;

ANIMALS; GENE TARGETING; GENETIC THERAPY; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 84863549706     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800958869     Document Type: Article

References (34)

1. Liu, X.Y. A new antitumor strategy: Cancer Gene-Viro-Therapy. Chinese J. Cancer Biotherapy, 2001, 8, 1.
2. Zhang, Z.L.; Zou, W.G.; Luo, C.X.; Li B.H.; Wang, J.H.; Sun, L.Y.; Qian, Q.J.; Liu, X.Y. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res, 2003, 13, 481-489.
3. Zhao, L.L.; Gu, J.F.; Dong, A.W.; Zhang, Y.; Zhong, L.; He, L.; Wang, Y.; Zhang, J.; Zhang Z.; Wang J.H.; Qian Q.J.; Qian, C.; Liu X.Y. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Human Gene Therapy, 2005, 16, 845-858.
4. Jiang, H.; Lin, J.J.; Su, Z.Z.; Goldstein, N.I.; Fisher, P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 1995, 11, 2477-2486.
5. Jiang, H.; Su, Z.Z.; Lin, J.J.; Goldstein, N.I.; Young, C.S.; Fisher, P.B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci U S A, 1996, 93, 9160-9165.
6. Pestka, S.; Krause, C.D.; Sarkar, D.; Walter, M.R.; Shi, Y.; Fisher, P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol, 2004, 22, 929-979.
7. Chaiken, I.M.; Williams, W.V. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design. Trends Biotechnol, 1996, 14, 369-375.
8. Fisher, P.B.; Is mda-7/IL-24 a "Magic Bullet" for cancer? Cancer Res, 2005, 65, 10128-10138.
9. Zhang, Q.; Nie, M.M.; Sham, J.; Su, C.Q.; Xue, H.B.; Chua, D.; Wang, W.G.; Cui, Z.F.; Liu, Y.J.; Liu, C.; Jiang, M.H.; Fang, G.E.; Liu, X.Y.; Wu, M.C.; Qian, Q.J. Effective gene-viral therapy for telomerasepositive cancers by selective replicative -competent adenovirus combining with endostatin gene. Cancer Res., 2004, 64, 5390-97.
10. Liu, X.Y.; Huang, W.L.; Qian, Q.J., Li, H.G.; Yang, D.Q.; Gu, J.F. Cancer Targeting Gene-Viro-Therapy (CTGVT) and its promising future. In "Recent Advances in Cancer Research and Therapy" (Xin Yuan Liu, Sidney Pestka, Yufang Shi eds), 2012, P. XX-XX. Elsevier Press.
11. Sarkar, D.; Su, Z.Z.; Vozhilla, N.; Park, E.S.; Gupta, P.; Fisher, P.B. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci, 2005, 102, 14034-14039.
12. Garber, K.; China approves world's first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst, 2006, 98, 298-300.
13. Chang, J.; Zhao, X.; Wu, X.; Guo, Y.; Guo, H.; Cao, J.; Guo, Y.; Lou, D.; Yu, D.; Li, J. A Phase I study of KH901, a conditionally replicating granulocyte- macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers. Cancer Biol. Ther., 2009, 8, 676-682.
14. Liu, X.Y.; Qiu, S.B.; Zou, W.G.; Pei, Z.F.; Gu, J.F.; Luo, C.X.; Ruan, H.M.; Chen, Y.; Qi, Y.P.; Qian C. Effective Gene- Virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5. Mol Ther, 2005, 11, 531-541.
15. Pei, Z.F.; Chu, L.; Zou, W.G.; Zhang, Z.; Qiu, S.; Qi, R.; Gu, J.; Qian, C.; Liu, X.Y. An oncolytic adenovrial vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology, 2004, 39, 1371-1381.
16. Zhang, Y.H.; Gu, J.F.; Zhao, L.L.; He, L.; Qian, W.; Wang, J.; Wang, Y.; Qian, Q.; Qian, C.; Wu, J.; Liu, X.Y. Completely elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosisinducing ligand gene therapy. Cancer Res, (Highlight paper) 2006, 66, 4291-4298.
17. Zhang Z.W.; Huang, Y.B.; Newman, K.; Gu, J.; Zhang, X.; Wu, H.; Zhao, M.; Xianyu, Z.; Liu X.Y. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis- inducing ligand against pancreatic cancer. Clin Cancer Res, 2009, 15, 5154-5160.
18. Chu, L.; Gu, J.F.; He, Z.N.; Xiao, T.; Liu, X. Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-κB survival signaling in hepatocellular carcinoma. Cancer Biology & Therapy, 2006, 5, 615-622.
19. Zhao L.L.; Dong, A.W.; Gu, J.F.; Liu, Z.; Zhang, Y.; Zhang, W.; Wang, Y.; He, L.; Qian, C.; Qian, Q.; Liu X.Y. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Therapy, 2006, 13, 1011-1022.
20. Fang J.; Qian, J.J.; Yi, S.; Harding, T.C.; Tu, G.H.; VanRoey, M.; Jooss, K. Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol, 2005, 23, 584-590.
21. Nowell, P.C. The clonal evolution of tumor cell populations. Science, 1976, 194, 23-28.
22. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M.A.; Dick, J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367, 645-648.
23. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
24. Pellicano, F.; Copland, M.; Jorgensen, H.G.; Mountford, J.; Leber, B.; Holyoake, T.L. BMS-214662 induces mitochondrial apoptosis in CML stem/progenitor cells, including CD34+38- cells, through activation of protein kinase C{beta}. Blood, 2009, 114, 4186-4196.
25. Armanios, M.; Greider, C.W.; Telomerase and cancer stem cells. Cold Spring Harb Symp Quant Biol, 2005, 70, 205-208.
26. Jiang, H.; Gomez-Manzano, C.; Aoki, H.; Alonso, M.M.; Kondo, S.; McCormick, F.; Xu, J.; Kondo, Y.; Bekele, B.N.; Colman, H.; Lang, F.F.; Fueyo, J. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst, 2007, 99,1410-1414.
27. Jiang, M.H.; Shi, W.F.; Zhang, Q.; Wang, X.; Guo, M.; Cui, Z.; Su, C.; Yang, Q.; Li, Y.; Sham, J.; Liu, X.; Wu, M.; Qian, Q. Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers. Clin Cancer Res, 2006, 12, 6179-6185.
28. Chen, J.; Su, C.Q.; Lu, Q.J. Shi, W.; Zhang, Q.; Wang, X.; Long, J.; Yang, Q.; Li, L.; Jia, X.; Wang, J.; Da, W.; Liu, X.; Wu, M.; Qian, Q. Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey. Molecular Cancer Therapy, 2008, 7, 1562-1568.
29. Cai, Y; Huang, W.D.; Liu, X.R.; Zhang, K.J.; Liu, X.Y. Mutual upregulation of TRAIL and IL-24 and completely eradication of hepatoma and gastric cancer in the CTGVT-DG strategy. Acta Biochim Biophys Sin, [online]
30. Liu, X.R; Cai, Y.; Cao, X; Wei, R.C.; Li, H.L.; Zhou, X.M.; Zhang, K.J.; Wu, S.; Qian, Q.J.; Cheng, B.; Huang, K.; Liu, X.Y. A new oncolytic adenoviral vector carrying dual tumor suppressor genes shows potent antitumor effect. Journal of Cellular and Molecular Medicine, [online]
31. Wei, R.C.; Cao X.; Gui J.H.; Zhou X.M.; Zhong D.; Yan Q.L.; Huang W.D.; Gu, J.F.; Zhao, F.L.; Liu, X.Y. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma. Hum Gene Ther, 2011, 22, 1109-1119.
32. Ding, M.; Cao, X.; Xu, H.N.; Fan, J.K.; Huang, W.D.; Yang, D.Q.; Li, Y.H.; Wang, J.; Li, R.S.; Liu, X.Y. Prostate cancer-specific and potent antitumor effect of a DD3-controlled oncolytic virus harboring the PTEN gene. Plos one, [online]
33. Evans J. Recent deal highlights hopes for cancer-killing viruses. Nat Med, 2011, 17: 268-269.
34. Breitbach C.J.; Burke J.; Jonker D.; Stephenson J.; Haas A.R.; Chow L.Q.; Nieva J et al. Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans. Nature, 2011, 477, 99-102.